Here's what I've learned so far:
As promised, all guinea pigs get the real gunk. Yippee!
However, Opexa has decided (as of just a few days ago) that they aren't going to disclose until the end of the trial which formula we were on for Part One. I'm not sure what to make of that one. On the one hand, the certainty of getting the vaccine should allay all fears but...
It also means that those patients who didn't respond very well to the real vaccine will have to invest a bit more time into this extension to know if Tovaxin works well enough for them to go the distance.
And in the old paperwork right in front of me, it looks like we're all going to have to endure the same old check for MRTCs and at least 10 weeks for culturing the vaccine.
I haven't gotten through a lot of these many, many pages yet but another piece of good news is that we don't have to do as many MRIs this time around! YESSS!
And, BEST news of all, it's right here in black and white that as long as we make the necessary MRTCs, we guinea pigs will get Tovaxin until it's FDA-approved and we can hit up our insurers for the cost.

So that's the scoop, so far!